/index.php?option=com_iwpfile&file=/dir_02/he2003_2183.pdf

/index.php?option=com_iwpfile&file=/dir_02/he2003_2182.pdf

/index.php?option=com_iwpfile&file=/dir_02/he2003_2181.pdf

H.R. 1 Motion H.R. 1 Vote

/index.php?option=com_iwpfile&file=/dir_02/he2003_2179.pdf

/index.php?option=com_iwpfile&file=/dir_02/he2003_2178.pdf

1

The Full Committee Markup scheduled for Wednesday, October 1, 2003, will now commence at 11:15 a.m. in 2123 Rayburn House Office Building to consider the following measures:

1. A resolution authorizing the issuance of subpoenas in connection with the Committee's investigation of the financial collapse of HealthSouth and related matters;

2. H.R. 2898, the E-911 Implementation Act of 2003;

3. H.R. 3140, Fairness to Contact Lens Consumers Act; and,

4. H.R. 3143, the International Consumer Protection Act of 2003.


DIABETES PREVENTION & TREATMENT ACT OF 2003 -- (Senate - September 29, 2003)

[Page: S12132]

---

Mr. KENNEDY. Mr. President, it is a privilege to be a sponsor with Senator Cochran of S. 1666, the Diabetes Prevention & Treatment Act of 2003.

Today, our health care system spends 1 out of every 4 Medicare dollars on diabetes. Almost 200,000 Americans die because of diabetes each year, and almost one-third of Americans alive today are not aware that they have the disease.


For Release: Immediately

Contact: HRSA Press Office

(301) 443-3376

Headline: HHS AWARDS $21.5 MILLION TO DEVELOP HIV PREVENTION METHODS, PROVIDE TREATMENT FOR PEOPLE WITH HIV/AIDS

HHS Secretary Tommy G. Thompson today announced 58 grants totaling more than $21.5 million to develop, implement and evaluate HIV prevention approaches and provide treatment for people living with HIV/AIDS.


="font-size: 14pt;" FACE="Times New Roman">FDA: FD&C Blue #1 Blamed For Numerous Deaths In Pulmonary Aspiration Patients

MedWatch - The FDA Safety Information and Adverse Event Reporting Program


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.